National Institutes of Health consensus development conference statement

Management of hepatitis B

Michael F. Sorrell, Edward A. Belongia, Jose Costa, Ilana F. Gareen, Jean L. Grem, John M. Inadomi, Earl R. Kern, James A. McHugh, Gloria M Petersen, Michael F. Rein, Doris B. Strader, Hartwell T. Trotter

Research output: Contribution to journalArticle

199 Citations (Scopus)

Abstract

National Institutes of Health (NIH) consensus and state-of-the-science statements are prepared by independent panels of health professionals and public representatives on the basis of 1) the results of a systematic literature review prepared under contract with the Agency for Healthcare Research and Quality (AHRQ); 2) presentations by investigators working in areas relevant to the conference questions during a 2-day public session; 3) questions and statements from conference attendees during open discussion periods that are part of the public session; and 4) closed deliberations by the panel during the remainder of the second day and morning of the third. This statement is an independent report of the panel and is not a policy statement of the National Institutes of Health or the U.S. government. The statement reflects the panel's assessment of medical knowledge available at the time the statement was written. Thus, it provides a "napshot in time" of the state of knowledge on the conference topic. When reading the statement, keep in mind that new knowledge is inevitably accumulating through medical research.

Original languageEnglish (US)
Pages (from-to)104-110
Number of pages7
JournalAnnals of Internal Medicine
Volume150
Issue number2
StatePublished - Jan 20 2009

Fingerprint

Consensus Development Conferences
National Institutes of Health (U.S.)
Hepatitis B
Health Services Research
Contracts
Biomedical Research
Reading
Public Health
Research Personnel

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Sorrell, M. F., Belongia, E. A., Costa, J., Gareen, I. F., Grem, J. L., Inadomi, J. M., ... Trotter, H. T. (2009). National Institutes of Health consensus development conference statement: Management of hepatitis B. Annals of Internal Medicine, 150(2), 104-110.

National Institutes of Health consensus development conference statement : Management of hepatitis B. / Sorrell, Michael F.; Belongia, Edward A.; Costa, Jose; Gareen, Ilana F.; Grem, Jean L.; Inadomi, John M.; Kern, Earl R.; McHugh, James A.; Petersen, Gloria M; Rein, Michael F.; Strader, Doris B.; Trotter, Hartwell T.

In: Annals of Internal Medicine, Vol. 150, No. 2, 20.01.2009, p. 104-110.

Research output: Contribution to journalArticle

Sorrell, MF, Belongia, EA, Costa, J, Gareen, IF, Grem, JL, Inadomi, JM, Kern, ER, McHugh, JA, Petersen, GM, Rein, MF, Strader, DB & Trotter, HT 2009, 'National Institutes of Health consensus development conference statement: Management of hepatitis B', Annals of Internal Medicine, vol. 150, no. 2, pp. 104-110.
Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM et al. National Institutes of Health consensus development conference statement: Management of hepatitis B. Annals of Internal Medicine. 2009 Jan 20;150(2):104-110.
Sorrell, Michael F. ; Belongia, Edward A. ; Costa, Jose ; Gareen, Ilana F. ; Grem, Jean L. ; Inadomi, John M. ; Kern, Earl R. ; McHugh, James A. ; Petersen, Gloria M ; Rein, Michael F. ; Strader, Doris B. ; Trotter, Hartwell T. / National Institutes of Health consensus development conference statement : Management of hepatitis B. In: Annals of Internal Medicine. 2009 ; Vol. 150, No. 2. pp. 104-110.
@article{ed1d52665007451ca589bdc445c3d119,
title = "National Institutes of Health consensus development conference statement: Management of hepatitis B",
abstract = "National Institutes of Health (NIH) consensus and state-of-the-science statements are prepared by independent panels of health professionals and public representatives on the basis of 1) the results of a systematic literature review prepared under contract with the Agency for Healthcare Research and Quality (AHRQ); 2) presentations by investigators working in areas relevant to the conference questions during a 2-day public session; 3) questions and statements from conference attendees during open discussion periods that are part of the public session; and 4) closed deliberations by the panel during the remainder of the second day and morning of the third. This statement is an independent report of the panel and is not a policy statement of the National Institutes of Health or the U.S. government. The statement reflects the panel's assessment of medical knowledge available at the time the statement was written. Thus, it provides a {"}napshot in time{"} of the state of knowledge on the conference topic. When reading the statement, keep in mind that new knowledge is inevitably accumulating through medical research.",
author = "Sorrell, {Michael F.} and Belongia, {Edward A.} and Jose Costa and Gareen, {Ilana F.} and Grem, {Jean L.} and Inadomi, {John M.} and Kern, {Earl R.} and McHugh, {James A.} and Petersen, {Gloria M} and Rein, {Michael F.} and Strader, {Doris B.} and Trotter, {Hartwell T.}",
year = "2009",
month = "1",
day = "20",
language = "English (US)",
volume = "150",
pages = "104--110",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "2",

}

TY - JOUR

T1 - National Institutes of Health consensus development conference statement

T2 - Management of hepatitis B

AU - Sorrell, Michael F.

AU - Belongia, Edward A.

AU - Costa, Jose

AU - Gareen, Ilana F.

AU - Grem, Jean L.

AU - Inadomi, John M.

AU - Kern, Earl R.

AU - McHugh, James A.

AU - Petersen, Gloria M

AU - Rein, Michael F.

AU - Strader, Doris B.

AU - Trotter, Hartwell T.

PY - 2009/1/20

Y1 - 2009/1/20

N2 - National Institutes of Health (NIH) consensus and state-of-the-science statements are prepared by independent panels of health professionals and public representatives on the basis of 1) the results of a systematic literature review prepared under contract with the Agency for Healthcare Research and Quality (AHRQ); 2) presentations by investigators working in areas relevant to the conference questions during a 2-day public session; 3) questions and statements from conference attendees during open discussion periods that are part of the public session; and 4) closed deliberations by the panel during the remainder of the second day and morning of the third. This statement is an independent report of the panel and is not a policy statement of the National Institutes of Health or the U.S. government. The statement reflects the panel's assessment of medical knowledge available at the time the statement was written. Thus, it provides a "napshot in time" of the state of knowledge on the conference topic. When reading the statement, keep in mind that new knowledge is inevitably accumulating through medical research.

AB - National Institutes of Health (NIH) consensus and state-of-the-science statements are prepared by independent panels of health professionals and public representatives on the basis of 1) the results of a systematic literature review prepared under contract with the Agency for Healthcare Research and Quality (AHRQ); 2) presentations by investigators working in areas relevant to the conference questions during a 2-day public session; 3) questions and statements from conference attendees during open discussion periods that are part of the public session; and 4) closed deliberations by the panel during the remainder of the second day and morning of the third. This statement is an independent report of the panel and is not a policy statement of the National Institutes of Health or the U.S. government. The statement reflects the panel's assessment of medical knowledge available at the time the statement was written. Thus, it provides a "napshot in time" of the state of knowledge on the conference topic. When reading the statement, keep in mind that new knowledge is inevitably accumulating through medical research.

UR - http://www.scopus.com/inward/record.url?scp=58749111990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58749111990&partnerID=8YFLogxK

M3 - Article

VL - 150

SP - 104

EP - 110

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 2

ER -